Assets Under Advice | Fees for 3years | |
35 lacs to 99 lacs | 3% + GST | |
1 Cr to 2.99 Cr | 2.5% + GST | |
3 Cr to 9.99 Cr | 2% + GST | |
10 Cr + | Customised Fees | |
GST @ 18% | ||
|
Please contact us for details | ||
|
NGL Fine-Chem is currently trading at Rs. 343.50, up by 26.90 points or 8.50% from its previous closing of Rs. 316.60 on the BSE.
The scrip opened at Rs. 340.00 and has touched a high and low of Rs. 349.90 and Rs. 325.00 respectively. So far 7352 shares were traded on the counter.
The BSE group 'XC' stock of face value Rs. 5 has touched a 52 week high of Rs. 470.00 on 01-Aug-2017 and a 52 week low of Rs. 251.50 on 17-Nov-2016.
Last one week high and low of the scrip stood at Rs. 349.90 and Rs. 309.00 respectively. The current market cap of the company is Rs. 212.49 crore.
The promoters holding in the company stood at 65.45%, while non-institutions held 34.55% stake in the company.
NGL Fine-chem is presently expanding its production capacity by incurring at total capital outlay of Rs 30 crore. The plant is ready for production and trial production runs have commenced from September 23, 2017.
NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1686.75 |
Dr. Reddys Lab | 1119.40 |
Cipla | 1454.85 |
Lupin | 1973.20 |
Zydus Lifesciences | 867.15 |
View more.. |